• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Hot off the press! The 1Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too! The 1Q10 OnBioVC Trend Analysis tracked, in aggregate, 74 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,260.1M. Compared to 1Q09 OnBioVC data, this investment activity represents a decrease in the [...]

So based upon the recent ruling of Myriad Genetics (NASDAQ: MYGN) invalidation of certain patents covering the BRCA1 and BRCA2 genes, I was planning on levering the news as fodder for an all out April Fools’ post effort, likely to have been something along the lines of ‘10,000 Gene-based Patents Overturned, Biotechnology Industry Implodes’. A [...]

  

to top of page...


 
  • The Latest LSDF Activity

    April 2010
    M T W T F S S
    « Feb   May »
     1234
    567891011
    12131415161718
    19202122232425
    2627282930  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com